Alpha-synuclein-induced nigrostriatal degeneration and pramipexole treatment disrupt frontostriatal plasticity
Marianne Benoit‐Marand(Inserm), Pierre‐Olivier Fernagut(Inserm)
Cited by 0
Related Papers
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
|Progress in Neurobiology|2015|472
Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?
|Progress in Neurobiology|2014|223
Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease
|Neurobiology of Disease|2016|29
Alpha-synuclein-induced nigrostriatal degeneration and pramipexole treatment disrupt frontostriatal plasticity
|npj Parkinson s Disease|2024|5